PeptideStack
5.2kquestions
20kanswers
220users

Does dimerisation of a GLP-1 receptor agonist at 2–8 °C show up as a loss of content or of purity?

Asked 26 Nov 2025Modified 8 months agoViewed 8.3k times
26

What I am working with: dimerisation · a GLP-1 receptor agonist · 2–8 °C.

I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious.

My background is quantitative but not chemical, so I can follow an equation more easily than a hand-wave.

What is the causal chain, and where does it stop being established?

peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

908 questionscontent-assay
content-assay

Quantified content: how many milligrams of peptide are actually in the vial, measured against a calibrated reference standard. A separate test…

476 questionspurity
purity

Purity as chromatographic area per cent - the fraction of detected material that is your target peak. It says nothing about how much material is…

833 questions
shareeditfollowflag
DW
askedDr_Elias_Weiss25k2726 Nov 2025
4Same situation here, so I will follow this one. – sample_id 8 months ago
3Is the material lyophilised or already in solution? Completely different answer. – plate_count_9k 6 months ago
add a comment

No answers yet

This question has not been answered. It has been viewed 8.3k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.